Bicalutamide

Bicalutamide is an important anti-androgen medication used in the treatment of prostate cancer. It works by blocking the action of the male hormone testosterone, slowing the growth and spread of cancer cells. Bicalutamide is used in combination with other medications, such as a luteinizing hormone releasing hormone (LHRH) agonist, to reduce the amount of testosterone in the body and reduce the severity of cancer symptoms. It is also used in hormone-sensitive prostate cancer as an alternative to surgery or radiation. By blocking the action of testosterone, bicalutamide can help to slow or stop the growth of cancer cells, making it an important treatment option for prostate cancer.

← International Journal of Prostate Cancer

Related Topics

Transurethral Resection Androgen Deprivation Therapy External Beam Radiation Biochemical Studies Cabazitaxel Androgen Receptor Abiraterone Acetate

Related Articles

1 journal(s) found

International Journal of Prostate Cancer

ISSN: Coming Soon
Type: Open Access Journal
Editor: Sam J. Brancato , Holden Comprehensive Cancer Center.
International Journal of Prostate Cancer is a world -wide, peer-reviewed open access journal. The main aim of this journal is to dedicate basic and clinical studies on prostate cancer and to provide rapid turn-around time possible for reviewing and publishing articles. Authors are encouraged to write - up research articles, review, letters, short-c
Aim & Scope Submit Manuscript Call for Papers